What is Euro-Med Laboratories Philippines Net Margin %?
Euro-Med Laboratories PhilippinesPHS:EURO 84 Net Margin % is 5.15% as of Mar. 2026, which is 15% below its 10-year median of 6.07. GuruFocus rates PHS:EURO with a GF Score™ of 84/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Euro-Med Laboratories Philippines ranks better than 55.13% on this metric.
The historical rank and industry rank for Euro-Med Laboratories Philippines's Net Margin % or its related term are showing as below:
PHS:EURO'
s Net Margin % Range Over the Past 10 Years
Min: 4.71 Med: 6.07 Max: 7.18
Current: 7.12
PHS:EURO's Net Margin % is ranked better than 55.13% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs PHS:EURO: 7.12
Euro-Med Laboratories Philippines (PHS:EURO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Euro-Med Laboratories Philippines Net Margin % Related Terms
Euro-Med Laboratories Philippines Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines Net Margin % Chart
PHS:EURO vs ZTS, UTHR, VTRS: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Net Margin % distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines (PHS:EURO) has a Net Margin % of 5.15% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 15% below median its historical median of 6.07. Over the past decade, Euro-Med Laboratories Philippines' Net Margin % has ranged from 4.71 to 7.18. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #429 out of 956 companies in the Drug Manufacturers industry, placing it in the top 44.9%.
Is Euro-Med Laboratories Philippines' Net Margin % too high?
Euro-Med Laboratories Philippines' current Net Margin % of 5.15% is 15% below median its 10-year median of 6.07. Over the past 10 years, this metric has ranged from a low of 4.71 to a high of 7.18. The Drug Manufacturers industry median Net Margin % is 5.56. Euro-Med Laboratories Philippines' value of 5.15% is 7.4% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #429 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #429 out of 956 companies for Net Margin %. This puts Euro-Med Laboratories Philippines in the upper half of its industry. The industry median Net Margin % is 5.56. Euro-Med Laboratories Philippines' value of 5.15% is 7.4% below this benchmark. Historically, Euro-Med Laboratories Philippines' own Net Margin % has ranged from 4.71 to 7.18 over the past decade. While the company's 10-year median is 6.07 vs. the industry median of 5.56, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current Net Margin % of 5.15% is 7.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current Net Margin % is 5.15%, which is 15% below median its own 10-year median of 6.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.08 — trading 5.9% above its estimated fair value. The current Net Margin % is 5.15%, which is 15% below median its 10-year median of 6.07 and 7.4% below the Drug Manufacturers industry median of 5.56. Euro-Med Laboratories Philippines' overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Net Margin % is 5.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.08 is trading 5.9% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
Net Margin %: 5.15% (15% below median its 10-year median of 6.07)
GF Value™: ₱1.02 vs. price of ₱1.08 (5.9% above fair value)
Industry Position: 7.4% below the Drug Manufacturers median (#429 of 956)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
84GF Score
Get the complete analysis for PHS:EURO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
